Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430908 · ClinicalTrials.gov registry record
Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 166
- Enrollment target
NCT03430908: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03430908 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03430908 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
This is a prospective, single-arm cohort, observational study to determine the incidence of gastric tube malposition during blind insertion by an anesthesia provider.
Interventions
- OTHER Blind Gastric Tube Placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2019-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430908
The ClinicalTrials.gov registry entry for NCT03430908 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blind Gastric Tube Placement is the first listed.
NCT03430908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03430908 about?
NCT03430908 is a clinical study titled "Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography". This is a prospective, single-arm cohort, observational study to determine the incidence of gastric tube malposition during blind insertion by an anesthesia provider.
What is the current status of trial NCT03430908?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2017-12-22. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT03430908?
The interventions under investigation include: Blind Gastric Tube Placement (OTHER).
Who is sponsoring clinical trial NCT03430908?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.